CEBPA and leukemia: Consistent with our pooled screening results, KRAB-mediated repression of the CEBPA +42 kb cisRE resulted in decreased CEBPA expression and maintained leukemia cells in a CD34+ stem cell–like state following MECOM degradation (Figure 5E-F; supplemental Figure 5B).